{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:12:19Z","timestamp":1792800739573,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["No 115976"],"award-info":[{"award-number":["No 115976"]}],"id":[{"id":"https:\/\/ror.org\/019af4n30","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London","id":[{"id":"https:\/\/ror.org\/015803449","id-type":"ROR","asserted-by":"crossref"}]},{"name":"MRC Proximity to Discovery: Industry Engagement Fund (External Collaboration, Innovation and Entrepreneurism: Translational Medicine in Exeter 2","award":["MR\/N015746\/1"],"award-info":[{"award-number":["MR\/N015746\/1"]}]},{"name":"NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula"},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre. A partnership between UCL and University College London Hospitals NHS Foundation Trust","id":[{"id":"https:\/\/ror.org\/042fqyp44","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Microglia are increasingly understood to play an important role in the pathogenesis of Alzheimer\u2019s disease. The rs75932628 (p.R47H)\n                      <jats:italic>TREM2<\/jats:italic>\n                      variant is a well-established risk factor for Alzheimer\u2019s disease. TREM2 is a microglial cell surface receptor. In this multi-modal\/multi-tracer PET\/MRI study we investigated the effect of\n                      <jats:italic>TREM2<\/jats:italic>\n                      p.R47H carrier status on microglial activation, tau and amyloid deposition, brain structure and cognitive profile.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We compared\n                      <jats:italic>TREM2<\/jats:italic>\n                      p.R47H carriers (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098; median age\u2009=\u200962.3) and participants with mild cognitive impairment (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098; median age\u2009=\u200970.7). Participants underwent two [\n                      <jats:sup>18<\/jats:sup>\n                      F]DPA-714 PET\/MRI scans to assess TSPO signal, indicative of microglial activation, before and after receiving the seasonal influenza vaccination, which was used as an immune stimulant. Participants also underwent [\n                      <jats:sup>18<\/jats:sup>\n                      F]florbetapir and [\n                      <jats:sup>18<\/jats:sup>\n                      F]AV1451 PET scans to assess amyloid and tau burden, respectively. Regional tau and TSPO signal were calculated for regions of interest linked to Braak stage. An additional comparison imaging healthy control group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098; median age\u2009=\u200945.5) had a single [\n                      <jats:sup>18<\/jats:sup>\n                      F]DPA-714 PET\/MRI. An expanded group of participants underwent neuropsychological testing, to determine if\n                      <jats:italic>TREM2<\/jats:italic>\n                      status influenced clinical phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to participants with mild cognitive impairment,\n                      <jats:italic>TREM2<\/jats:italic>\n                      carriers had lower TSPO signal in Braak II (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04) and Braak III (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.046) regions, despite having a similar burden of tau and amyloid. There were trends to suggest reduced microglial activation following influenza vaccine in\n                      <jats:italic>TREM2<\/jats:italic>\n                      carriers. Tau deposition in the Braak VI region was higher in\n                      <jats:italic>TREM2<\/jats:italic>\n                      carriers (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04). Furthermore, compared to healthy controls\n                      <jats:italic>TREM2<\/jats:italic>\n                      carriers had smaller caudate (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02), total brain (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.049) and white matter volumes (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02); and neuropsychological assessment revealed worse ADAS-Cog13 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) and Delayed Matching to Sample (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007) scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>TREM2<\/jats:italic>\n                      p.R47H carriers had reduced levels of microglial activation in brain regions affected early in the Alzheimer\u2019s disease course and differences in brain structure and cognition. Changes in microglial response may underlie the increased Alzheimer\u2019s disease risk in\n                      <jats:italic>TREM2<\/jats:italic>\n                      p.R47H carriers. Future therapeutic agents in Alzheimer\u2019s disease should aim to enhance protective microglial actions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-023-02945-0","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T14:09:05Z","timestamp":1700575745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal\/multi-tracer PET\/MRI imaging study with influenza vaccine immune challenge"],"prefix":"10.1186","volume":"20","author":[{"given":"Oliver","family":"Cousins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polena","family":"Valkimadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Creese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Arathimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Hampshire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aasland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Velayudhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramla","family":"Awais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"\u00c5rstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Turkheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"2945_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21:1359\u201369.","journal-title":"Nat Neurosci"},{"key":"2945_CR2","first-page":"245","volume":"8","author":"AK Hodges","year":"2021","unstructured":"Hodges AK, Piers TM, Collier D, Cousins O, Pocock JM. Pathways linking Alzheimer\u2019s disease risk genes expressed highly in microglia. Neuroimmunol Neuroinflamm. 2021;8:245\u201368.","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"2945_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336.","journal-title":"Nat Genet"},{"key":"2945_CR4","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat Commun. 2015;6:6176.","journal-title":"Nat Commun"},{"key":"2945_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CY Lee","year":"2010","unstructured":"Lee CY, Landreth GE. The role of microglia in amyloid clearance from the AD brain. J Neural Transm (Vienna). 2010;117:949\u201360.","journal-title":"J Neural Transm (Vienna)"},{"key":"2945_CR6","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140:3286\u2013300.","journal-title":"Brain"},{"key":"2945_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"2945_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/JAD-150704","volume":"50","author":"M Bol\u00f3s","year":"2016","unstructured":"Bol\u00f3s M, Llorens-Mart\u00edn M, Jurado-Arjona J, Hern\u00e1ndez F, R\u00e1bano A, Avila J. Direct evidence of internalization of tau by microglia in vitro and in vivo. J Alzheimers Dis. 2016;50:77\u201387.","journal-title":"J Alzheimers Dis"},{"key":"2945_CR9","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK, et al. Microglial activation and tau propagate jointly across Braak stages. Nat Med. 2021;27:1592\u20139.","journal-title":"Nat Med"},{"key":"2945_CR10","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, K\u00fcgler S, Ikezu T. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18:1584\u201393.","journal-title":"Nat Neurosci"},{"key":"2945_CR11","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON, Jiang S, Cardona A, Ransohoff RM, Lamb BT, Bhaskar K. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain. 2015;138:1738\u201355.","journal-title":"Brain"},{"key":"2945_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"2945_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"2945_CR14","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi Y, Liu CC, Painter MM, Chen XF, Verbeeck C, Zheng H, Li X, Rademakers R, Kang SS, Xu H, et al. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J Biol Chem. 2015;290:26043\u201350.","journal-title":"J Biol Chem"},{"key":"2945_CR15","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","volume":"290","author":"CC Bailey","year":"2015","unstructured":"Bailey CC, DeVaux LB, Farzan M. The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E. J Biol Chem. 2015;290:26033\u201342.","journal-title":"J Biol Chem"},{"key":"2945_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, Sun Y, Zhu B, Pi\u00f1a-Crespo JC, Zhang M, et al. TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron. 2018;97:1023-1031.e1027.","journal-title":"Neuron"},{"key":"2945_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160:1061\u201371.","journal-title":"Cell"},{"key":"2945_CR18","doi-asserted-by":"publisher","first-page":"12634","DOI":"10.1074\/jbc.RA118.002352","volume":"293","author":"A Sudom","year":"2018","unstructured":"Sudom A, Talreja S, Danao J, Bragg E, Kegel R, Min X, Richardson J, Zhang Z, Sharkov N, Marcora E, et al. Molecular basis for the loss-of-function effects of the Alzheimer\u2019s disease-associated R47H variant of the immune receptor TREM2. J Biol Chem. 2018;293:12634\u201346.","journal-title":"J Biol Chem"},{"key":"2945_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1474-4422(18)30232-1","volume":"17","author":"S Carmona","year":"2018","unstructured":"Carmona S, Zahs K, Wu E, Dakin K, Bras J, Guerreiro R. The role of TREM2 in Alzheimer\u2019s disease and other neurodegenerative disorders. Lancet Neurol. 2018;17:721\u201330.","journal-title":"Lancet Neurol"},{"key":"2945_CR20","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1016\/j.neurobiolaging.2014.06.007","volume":"35","author":"EO Luis","year":"2014","unstructured":"Luis EO, Ortega-Cubero S, Lamet I, Razquin C, Cruchaga C, Benitez BA, Lorenzo E, Irigoyen J, Pastor MA, Pastor P. (ADNI) AsDNI: Frontobasal gray matter loss is associated with the TREM2 p.R47H variant. Neurobiol Aging. 2014;35:2681\u201390.","journal-title":"Neurobiol Aging"},{"key":"2945_CR21","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jalz.2014.05.1751","volume":"10","author":"CF Slattery","year":"2014","unstructured":"Slattery CF, Beck JA, Harper L, Adamson G, Abdi Z, Uphill J, Campbell T, Druyeh R, Mahoney CJ, Rohrer JD, et al. R47H TREM2 variant increases risk of typical early-onset Alzheimer\u2019s disease but not of prion or frontotemporal dementia. Alzheimers Dement. 2014;10:602-608.e604.","journal-title":"Alzheimers Dement"},{"key":"2945_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1001\/jamaneurol.2015.0979","volume":"72","author":"O Korvatska","year":"2015","unstructured":"Korvatska O, Leverenz JB, Jayadev S, McMillan P, Kurtz I, Guo X, Rumbaugh M, Matsushita M, Girirajan S, Dorschner MO, et al. R47H variant of TREM2 associated with Alzheimer disease in a large late-onset family: clinical, genetic, and neuropathological study. JAMA Neurol. 2015;72:920\u20137.","journal-title":"JAMA Neurol"},{"key":"2945_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2015.12.023","volume":"40","author":"MK Lupton","year":"2016","unstructured":"Lupton MK, Strike L, Hansell NK, Wen W, Mather KA, Armstrong NJ, Thalamuthu A, McMahon KL, de Zubicaray GI, Assareh AA, et al. The effect of increased genetic risk for Alzheimer\u2019s disease on hippocampal and amygdala volume. Neurobiol Aging. 2016;40:68\u201377.","journal-title":"Neurobiol Aging"},{"issue":"2443","key":"2945_CR24","first-page":"e2421","volume":"36","author":"SL Rosenthal","year":"2015","unstructured":"Rosenthal SL, Bamne MN, Wang X, Berman S, Snitz BE, Klunk WE, Sweet RA, Demirci FY, Lopez OL, Kamboh MI. More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer\u2019s disease risk. Neurobiol Aging. 2015;36(2443):e2421-2446.","journal-title":"Neurobiol Aging"},{"key":"2945_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, Rezzonico MG, Imperio J, Lalehzadeh G, Huntley MA, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron. 2021;109:1283-1301.e1286.","journal-title":"Neuron"},{"key":"2945_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1042\/BST20150058","volume":"43","author":"FE Turkheimer","year":"2015","unstructured":"Turkheimer FE, Rizzo G, Bloomfield PS, Howes O, Zanotti-Fregonara P, Bertoldo A, Veronese M. The methodology of TSPO imaging with positron emission tomography. Biochem Soc Trans. 2015;43:586\u201392.","journal-title":"Biochem Soc Trans"},{"key":"2945_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9:971\u201388.","journal-title":"Nat Rev Drug Discov"},{"key":"2945_CR28","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay M-E, Aguzzi A, Ajami B, Amit I, Audinat E, Bechmann I, Bennett M. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110:3458\u201383.","journal-title":"Neuron"},{"key":"2945_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2967\/jnumed.108.058669","volume":"50","author":"F Chauveau","year":"2009","unstructured":"Chauveau F, Van Camp N, Doll\u00e9 F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med. 2009;50:468\u201376.","journal-title":"J Nucl Med"},{"key":"2945_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbi.2015.11.006","volume":"53","author":"F Qi","year":"2016","unstructured":"Qi F, Yang J, Xia Y, Yuan Q, Guo K, Zou J, Yao Z. A(H1N1) vaccination recruits T lymphocytes to the choroid plexus for the promotion of hippocampal neurogenesis and working memory in pregnant mice. Brain Behav Immun. 2016;53:72\u201383.","journal-title":"Brain Behav Immun"},{"key":"2945_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12974-020-01741-4","volume":"17","author":"Y Yang","year":"2020","unstructured":"Yang Y, He Z, Xing Z, Zuo Z, Yuan L, Wu Y, Jiang M, Qi F, Yao Z. Influenza vaccination in early Alzheimer\u2019s disease rescues amyloidosis and ameliorates cognitive deficits in APP\/PS1 mice by inhibiting regulatory T cells. J Neuroinflamm. 2020;17:65.","journal-title":"J Neuroinflamm"},{"key":"2945_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1749-6632.2009.05064.x","volume":"1180","author":"S Lovestone","year":"2009","unstructured":"Lovestone S, Francis P, Kloszewska I, Mecocci P, Simmons A, Soininen H, Spenger C, Tsolaki M, Vellas B, Wahlund LO, et al. AddNeuroMed\u2013the European collaboration for the discovery of novel biomarkers for Alzheimer\u2019s disease. Ann N Y Acad Sci. 2009;1180:36\u201346.","journal-title":"Ann N Y Acad Sci"},{"key":"2945_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12164","volume":"13","author":"B Creese","year":"2021","unstructured":"Creese B, Arathimos R, Brooker H, Aarsland D, Corbett A, Lewis C, Ballard C, Ismail Z. Genetic risk for Alzheimer\u2019s disease, cognition, and mild behavioral impairment in healthy older adults. Alzheimers Dement (Amst). 2021;13: e12164.","journal-title":"Alzheimers Dement (Amst)"},{"key":"2945_CR34","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412\u20134.","journal-title":"Neurology"},{"key":"2945_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37\u201349.","journal-title":"J Psychiatr Res"},{"key":"2945_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50\u20135.","journal-title":"Br J Med Psychol"},{"key":"2945_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","volume":"38","author":"RS Marin","year":"1991","unstructured":"Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 1991;38:143\u201362.","journal-title":"Psychiatry Res"},{"key":"2945_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/00006842-200205000-00016","volume":"64","author":"RG Logsdon","year":"2002","unstructured":"Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64:510\u20139.","journal-title":"Psychosom Med"},{"key":"2945_CR39","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121\u20133.","journal-title":"Arch Neurol"},{"key":"2945_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"2945_CR41","first-page":"167","volume":"14","author":"TN Tombaugh","year":"1999","unstructured":"Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999;14:167\u201377.","journal-title":"Arch Clin Neuropsychol"},{"key":"2945_CR42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1017\/S1355617709090626","volume":"15","author":"I S\u00e1nchez-Cubillo","year":"2009","unstructured":"S\u00e1nchez-Cubillo I, Peri\u00e1\u00f1ez JA, Adrover-Roig D, Rodr\u00edguez-S\u00e1nchez JM, R\u00edos-Lago M, Tirapu J, Barcel\u00f3 F. Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition\/interference control, and visuomotor abilities. J Int Neuropsychol Soc. 2009;15:438\u201350.","journal-title":"J Int Neuropsychol Soc"},{"issue":"Suppl 2","key":"2945_CR43","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","volume":"11","author":"RC Mohs","year":"1997","unstructured":"Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer\u2019s Disease Assessment Scale that broaden its scope. The Alzheimer\u2019s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(Suppl 2):S13-21.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2945_CR44","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/gps.4042","volume":"29","author":"O Juncos-Rabad\u00e1n","year":"2014","unstructured":"Juncos-Rabad\u00e1n O, Pereiro AX, Facal D, Reboredo A, Lojo-Seoane C. Do the Cambridge Neuropsychological Test Automated Battery episodic memory measures discriminate amnestic mild cognitive impairment? Int J Geriatr Psychiatry. 2014;29:602\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2945_CR45","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B. FreeSurfer. Neuroimage. 2012;62:774\u201381.","journal-title":"Neuroimage"},{"key":"2945_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341\u201355.","journal-title":"Neuron"},{"key":"2945_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnins.2012.00171","volume":"6","author":"A Klein","year":"2012","unstructured":"Klein A, Tourville J. 101 labeled brain images and a consistent human cortical labeling protocol. Front Neurosci. 2012;6:171.","journal-title":"Front Neurosci"},{"key":"2945_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117002","volume":"224","author":"F Alfaro-Almagro","year":"2021","unstructured":"Alfaro-Almagro F, McCarthy P, Afyouni S, Andersson JLR, Bastiani M, Miller KL, Nichols TE, Smith SM. Confound modelling in UK Biobank brain imaging. Neuroimage. 2021;224: 117002.","journal-title":"Neuroimage"},{"key":"2945_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1457","volume":"9","author":"K Wei","year":"2019","unstructured":"Wei K, Tran T, Chu K, Borzage MT, Braskie MN, Harrington MG, King KS. White matter hypointensities and hyperintensities have equivalent correlations with age and CSF \u03b2-amyloid in the nondemented elderly. Brain Behav. 2019;9: e01457.","journal-title":"Brain Behav"},{"key":"2945_CR50","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, et al. PET imaging of tau deposition in the aging human brain. Neuron. 2016;89:971\u201382.","journal-title":"Neuron"},{"key":"2945_CR51","first-page":"232","volume":"10","author":"L Lemoine","year":"2018","unstructured":"Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A. Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding. Alzheimer\u2019s Dementia Diagn Assess Dis Monit. 2018;10:232\u20136.","journal-title":"Alzheimer's Dementia Diagn Assess Dis Monit"},{"key":"2945_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40658-019-0269-4","volume":"7","author":"J Mackewn","year":"2020","unstructured":"Mackewn J, Stirling J, Jeljeli S, Gould S, Johnstone R, Merida I, Pike L, McGinnity C, Beck K, Howes O. Practical issues and limitations of brain attenuation correction on a simultaneous PET-MR scanner. EJNMMI Physics. 2020;7:1\u201317.","journal-title":"EJNMMI Physics"},{"key":"2945_CR53","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2967\/jnumed.108.050583","volume":"49","author":"G Tomasi","year":"2008","unstructured":"Tomasi G, Edison P, Bertoldo A, Roncaroli F, Singh P, Gerhard A, Cobelli C, Brooks DJ, Turkheimer FE. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer\u2019s disease. J Nucl Med. 2008;49:1249\u201356.","journal-title":"J Nucl Med"},{"key":"2945_CR54","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/jcbfm.2012.59","volume":"32","author":"M Yaqub","year":"2012","unstructured":"Yaqub M, van Berckel BN, Schuitemaker A, Hinz R, Turkheimer FE, Tomasi G, Lammertsma AA, Boellaard R. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies. J Cereb Blood Flow Metab. 2012;32:1600\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2945_CR55","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/0271678X17742004","volume":"39","author":"G Rizzo","year":"2019","unstructured":"Rizzo G, Veronese M, Tonietto M, Bodini B, Stankoff B, Wimberley C, Lavisse S, Bottlaender M, Bloomfield PS, Howes O, et al. Generalization of endothelial modelling of TSPO PET imaging: considerations on tracer affinities. J Cereb Blood Flow Metab. 2019;39:874\u201385.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2945_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/0271678X17692599","volume":"38","author":"D Garc\u00eda-Lorenzo","year":"2018","unstructured":"Garc\u00eda-Lorenzo D, Lavisse S, Leroy C, Wimberley C, Bodini B, Remy P, Veronese M, Turkheimer F, Stankoff B, Bottlaender M. Validation of an automatic reference region extraction for the quantification of [18F] DPA-714 in dynamic brain PET studies. J Cereb Blood Flow Metab. 2018;38:333\u201346.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2945_CR57","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1088\/0031-9155\/61\/22\/7975","volume":"61","author":"BA Thomas","year":"2016","unstructured":"Thomas BA, Cuplov V, Bousse A, Mendes A, Thielemans K, Hutton BF, Erlandsson K. PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography. Phys Med Biol. 2016;61:7975\u201393.","journal-title":"Phys Med Biol"},{"key":"2945_CR58","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2967\/jnumed.116.175273","volume":"58","author":"SL Baker","year":"2017","unstructured":"Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ. Reference tissue-based kinetic evaluation of 18F-AV-1451 for Tau imaging. J Nucl Med. 2017;58:332\u20138.","journal-title":"J Nucl Med"},{"key":"2945_CR59","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2967\/jnumed.109.069088","volume":"51","author":"DF Wong","year":"2010","unstructured":"Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasi\u0107 JR, Ye W, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010;51:913\u201320.","journal-title":"J Nucl Med"},{"key":"2945_CR60","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ana.23908","volume":"74","author":"SM Landau","year":"2013","unstructured":"Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust WJ. Initiative AsDN: comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid. Ann Neurol. 2013;74:826\u201336.","journal-title":"Ann Neurol"},{"key":"2945_CR61","unstructured":"Gunn R, Coello C, Searle G. Molecular imaging and kinetic analysis toolbox (MIAKAT)\u2014a quantitative software package for the analysis of PET neuroimaging data. Soc Nuclear Med; 2016;57(supplement 2):1928."},{"key":"2945_CR62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi AC, Searle GE, Tzimopoulou S, Salinas C, Beaver JD, Jenkinson M, Laruelle M, Rabiner EA, Gunn RN. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage. 2011;54:264\u201377.","journal-title":"Neuroimage"},{"key":"2945_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2288-10-18","volume":"10","author":"L Coudeville","year":"2010","unstructured":"Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol. 2010;10:18.","journal-title":"BMC Med Res Methodol"},{"key":"2945_CR64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1742-2094-9-232","volume":"9","author":"A Kumar","year":"2012","unstructured":"Kumar A, Muzik O, Shandal V, Chugani D, Chakraborty P, Chugani HT. Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11)C-[R]-PK11195 PET. J Neuroinflamm. 2012;9:232.","journal-title":"J Neuroinflamm"},{"key":"2945_CR65","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1172\/JCI138179","volume":"130","author":"M Gratuze","year":"2020","unstructured":"Gratuze M, Leyns CE, Sauerbeck AD, St-Pierre MK, Xiong M, Kim N, Serrano JR, Tremblay M, Kummer TT, Colonna M, et al. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J Clin Invest. 2020;130:4954\u201368.","journal-title":"J Clin Invest"},{"key":"2945_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","volume":"13","author":"PJ Cheng-Hathaway","year":"2018","unstructured":"Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS, von Saucken VE, Williams RY, Karlo JC, Moutinho M, et al. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13:29.","journal-title":"Mol Neurodegener"},{"key":"2945_CR67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"2945_CR68","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","volume":"17","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, Datta D, Del Tredici K, Braak H. Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease. Alzheimers Dement. 2021;17:115\u201324.","journal-title":"Alzheimers Dement"},{"key":"2945_CR69","first-page":"792","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain. 2017;140:792\u2013803.","journal-title":"Brain"},{"key":"2945_CR70","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1096\/fj.201902447R","volume":"34","author":"TM Piers","year":"2020","unstructured":"Piers TM, Cosker K, Mallach A, Johnson GT, Guerreiro R, Hardy J, Pocock JM. A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia. FASEB J. 2020;34:2436\u201350.","journal-title":"FASEB J"},{"key":"2945_CR71","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1186\/s12889-021-11736-2","volume":"21","author":"S Oakley","year":"2021","unstructured":"Oakley S, Bouchet J, Costello P, Parker J. Influenza vaccine uptake among at-risk adults (aged 16\u201364 years) in the UK: a retrospective database analysis. BMC Public Health. 2021;21:1734.","journal-title":"BMC Public Health"},{"key":"2945_CR72","doi-asserted-by":"publisher","first-page":"12468","DOI":"10.1073\/pnas.1511003112","volume":"112","author":"CM Sandiego","year":"2015","unstructured":"Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, Matuskey D, Lee JY, O\u2019Connor KC, Huang Y, et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A. 2015;112:12468\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2945_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s000110050408","volume":"48","author":"H Vedder","year":"1999","unstructured":"Vedder H, Schreiber W, Yassouridis A, Gudewill S, Galanos C, Pollm\u00e4cher T. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm Res. 1999;48:67\u201374.","journal-title":"Inflamm Res"},{"key":"2945_CR74","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41398-020-0768-z","volume":"10","author":"MA Nettis","year":"2020","unstructured":"Nettis MA, Veronese M, Nikkheslat N, Mariani N, Lombardo G, Sforzini L, Enache D, Harrison NA, Turkheimer FE, Mondelli V, Pariante CM. PET imaging shows no changes in TSPO brain density after IFN-\u03b1 immune challenge in healthy human volunteers. Transl Psychiatry. 2020;10:89.","journal-title":"Transl Psychiatry"},{"key":"2945_CR75","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bbi.2020.10.025","volume":"91","author":"FE Turkheimer","year":"2021","unstructured":"Turkheimer FE, Althubaity N, Schubert J, Nettis MA, Cousins O, Dima D, Mondelli V, Bullmore ET, Pariante C, Veronese M. Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: implications for inflammation and depression. Brain Behav Immun. 2021;91:487\u201397.","journal-title":"Brain Behav Immun"},{"key":"2945_CR76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/WAD.0000000000000196","volume":"31","author":"GS Day","year":"2017","unstructured":"Day GS, Gordon BA, Jackson K, Christensen JJ, Rosana Ponisio M, Su Y, Ances BM, Benzinger TLS, Morris JC. Tau-PET binding distinguishes patients with early-stage posterior cortical atrophy from amnestic Alzheimer disease dementia. Alzheimer Dis Assoc Disord. 2017;31:87\u201393.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"2945_CR77","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00401-022-02495-4","volume":"144","author":"B Kim","year":"2022","unstructured":"Kim B, Suh E, Nguyen AT, Prokop S, Mikytuck B, Olatunji OA, Robinson JL, Grossman M, Phillips JS, Irwin DJ. TREM2 risk variants are associated with atypical Alzheimer\u2019s disease. Acta Neuropatholog. 2022;144(6):1085\u2013102.","journal-title":"Acta Neuropatholog."},{"key":"2945_CR78","first-page":"2740","volume":"141","author":"M Dani","year":"2018","unstructured":"Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, Hinz R, Biju M, Kuruvilla T, Brooks DJ, Edison P. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer\u2019s disease. Brain. 2018;141:2740\u201354.","journal-title":"Brain"},{"key":"2945_CR79","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1017\/S0033291720001142","volume":"51","author":"M Campos-Magdaleno","year":"2021","unstructured":"Campos-Magdaleno M, Leiva D, Pereiro AX, Lojo-Seoane C, Mallo SC, Facal D, Juncos-Rabad\u00e1n O. Changes in visual memory in mild cognitive impairment: a longitudinal study with CANTAB. Psychol Med. 2021;51:2465\u201375.","journal-title":"Psychol Med"},{"key":"2945_CR80","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jnnp.74.6.825-a","volume":"74","author":"D Soragna","year":"2003","unstructured":"Soragna D, Papi L, Ratti MT, Sestini R, Tupler R, Montalbetti L. An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene. J Neurol Neurosurg Psychiatry. 2003;74:825\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2945_CR81","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.neurobiolaging.2010.05.002","volume":"31","author":"SK Madsen","year":"2010","unstructured":"Madsen SK, Ho AJ, Hua X, Saharan PS, Toga AW, Jack CR, Weiner MW, Thompson PM. Initiative AsDN: 3D maps localize caudate nucleus atrophy in 400 Alzheimer\u2019s disease, mild cognitive impairment, and healthy elderly subjects. Neurobiol Aging. 2010;31:1312\u201325.","journal-title":"Neurobiol Aging"},{"key":"2945_CR82","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis. 2020;12:1179573520907397.","journal-title":"J Cent Nerv Syst Dis"},{"key":"2945_CR83","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00259-019-04403-7","volume":"46","author":"J Tuisku","year":"2019","unstructured":"Tuisku J, Plav\u00e9n-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Br\u00fcck A, Carson RE, Chen M-K, Cosgrove KP, Ekblad L. Effects of age, BMI and sex on the glial cell marker TSPO\u2014a multicentre [11 C] PBR28 HRRT PET study. Eur J Nucl Med Mol Imaging. 2019;46:2329\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2945_CR84","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","volume":"141","author":"E Gerrits","year":"2021","unstructured":"Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, Mulder J, Kummer M, M\u00f6ller T, Biber K, et al. Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer\u2019s disease. Acta Neuropathol. 2021;141:681\u201396.","journal-title":"Acta Neuropathol"},{"key":"2945_CR85","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","volume":"32","author":"S Lavisse","year":"2012","unstructured":"Lavisse S, Guillermier M, H\u00e9rard AS, Petit F, Delahaye M, Van Camp N, Ben Haim L, Lebon V, Remy P, Doll\u00e9 F, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci. 2012;32:10809\u201318.","journal-title":"J Neurosci"},{"key":"2945_CR86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12974-020-01980-5","volume":"18","author":"M Fassler","year":"2021","unstructured":"Fassler M, Rappaport MS, Cu\u00f1o CB, George J. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer\u2019s disease models. J Neuroinflamm. 2021;18:19.","journal-title":"J Neuroinflamm"},{"key":"2945_CR87","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, Wilcock DM. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflamm. 2020;17:238.","journal-title":"J Neuroinflamm"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02945-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02945-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02945-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T14:18:42Z","timestamp":1700576322000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02945-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2945"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02945-0","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for all research participants recruited to PHAGO was obtained according to the Declaration of Helsinki 1975, as revised in 2008. Protocols and procedures contributing to this work complied with the ethical standards of the relevant national and institutional committees on human experimentation and were approved by the London-Bloomsbury ethics committee (reference number 17\/LO\/1266).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}